Fundraising FoxAllergen Research
San Mateo, US · Founded 2011 · Delaware corporation · 4 known investors
Find your way into Allergen Research
Sign up to find every way you can get introduced to Allergen Research
- Your email: who you already know at Allergen Research, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Allergen Research team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
VC
Victor ColungaExecutive
SG
Stephen G. Dilly, Jr.Executive
Board
J(
Joonkyoo (Anthony) YunBoard director
SD
Stacey D. SeltzerBoard director
JT
James TananbaumBoard director
PE
BL
Bryan L. WalserBoard director
Investors · 4
Longitude CapitalreportedMenlo Park · $10M – $30M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$334.7M disclosed across 3 rounds · 2015–2018
▶$98MraisedNov 2018 · 1 investors · Other Health CareRule 506(b)
▶$98MraisedNov 2018 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Eric H. BjerkholtExecutive Officer
- Mark D. McDadeDirector
- Patrick G. EnrightDirector
- Brett K. HaumannDirector
- Daniel C. AdelmanExecutive Officer
- Mary M. RozenmanExecutive Officer
- Susan E. BarrowcliffeExecutive Officer
- Douglas T. SheehyExecutive Officer
- Stacey D. SeltzerDirector
- Gregory BeharDirector
- Jayson D.A. DallasExecutive Officer, Director
- Kathryn E. FalbergDirector
- Mark T. IwickiDirector
- Offering amount
- $98M
- Amount sold
- $98M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$156.7MraisedMar 2018 · 2 investors · Other Health CareRule 506(b)
▶$156.7MraisedMar 2018 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark D. McDadeDirector
- Kathryn E. FalbergDirector
- Jeffrey H. KnappExecutive Officer
- Patrick G. EnrightDirector
- Daniel C. AdelmanExecutive Officer
- Susan E. BarrowcliffeExecutive Officer
- Stephen G. Dilly, Jr.Executive Officer, Director
- Gregory BeharDirector
- Mark T. IwickiDirector
- Mary M. RozenmanExecutive Officer
- Stacey D. SeltzerDirector
- Eric H. BjerkholtExecutive Officer
- Douglas T. SheehyExecutive Officer
- Offering amount
- $156.7M
- Amount sold
- $156.7M
- Minimum investment
- $1
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$80MraisedMar 2015 · 10 investors · Other Health CareRule 506(b)
▶$80MraisedMar 2015 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joonkyoo (Anthony) YunDirector
- Stacey D. SeltzerDirector
- James TananbaumDirector
- Victor ColungaExecutive Officer
- Bryan L. WalserDirector
- Stephen G. Dilly, Jr.Executive Officer, Director
- Patrick EnrightDirector
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Allergen Research's investors?
- Allergen Research's investors include Aisling Capital, Foresite Capital, Longitude Capital, Qiming Healthcare.
- How much funding has Allergen Research raised?
- Allergen Research has disclosed $334.7M raised across 3 rounds.
- Where is Allergen Research headquartered?
- Allergen Research is headquartered in San Mateo, US.